Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 6Other hematologic neoplasm 2Myeloid 2Gynecologic 2Sarcoma 1Other 1Lymphoid 1

Conditions

Obesity 1Neoplasm Metastasis 1Endometrial Neoplasms 1Disease 1Carcinosarcoma 1

Interventions

Tirzepatide 9Methods 8Educational Status 8Exercise 6Early Intervention, Educational 6Interviews as Topic 5Counseling 5semaglutide 3Surveys and Questionnaires 3Standard of Care 3Resistance Training 3Radiotherapy 3Nutrition Assessment 3naldemedine 2Transcutaneous Electric Nerve Stimulation 2Specimen Handling 2Progestins 2Mouthwashes 2Mindfulness 2Megestrol Acetate 2Letrozole 2Health Promotion 2Exercise Test 2Echocardiography 2Drug Therapy 2Diet Therapy 2Bupropion 2mirabegron 1ma zi ren wan 1isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
TIC10 compound × Other × 1 year × Clear all
NCT05542407 2026-01-29

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
58 enrolled
GynecologicOtherSarcoma

Carcinosarcoma, Disease, Neoplasm Metastasis, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡